BOSTON — Living Proof has signed a 14,085-square-foot lease in Boston’s Seaport District. The provider of hair care products will relocate its operations from the Innovation & Design Building to the entire fifth floor of the office and life sciences building at 12 Farnsworth St. Tim Lahey of CBRE represented the tenant in the lease negotiations. Eric Smith and Lauren Drakeley, also with CBRE, represented the landlord, Phase 3 Real Estate Partners.
LAKEWOOD, COLO. — The U.S. General Services Administration (GSA), U.S. Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) have broken ground on a $228 million food lab in Lakewood, a southwestern suburb of Denver. According to Colorado Politics, the site is located within Denver Federal Center, a complex that spans 4 million square feet of space across 90 buildings. The complex houses operations of 28 federal agencies representing some 6,200 employees, according to the local publication. The new food lab will include 16,500 square feet of new lab space for microbiology functions and 14,000 square feet for chemistry initiatives. The facility will be used to support the FDA’s management of foodborne illness outbreaks and ensure product safety for food, drugs and cosmetics. Completion is slated for 2029. The exterior design of the facility will feature a neoclassical style that reflects President Donald Trump’s executive order to “making federal architecture beautiful again.” The interior of the facility will include controlled access and a sustained directional airflow system. Additionally, the property will be the FDA’s only Biosafety Level 3 facility west of the Mississippi River. “Laboratories are vital to the FDA’s mission to ensure the safety of …
PROVIDENCE, R.I. — Newmark has brokered the $68 million sale of a life sciences and biomanufacturing facility in Providence. The 122,507-square-foot facility at 100 Technology Way was originally developed in 1993 and was fully leased at the time of sale to Organogenesis (NASDAQ: ORGO), a provider of regenerative medicine solutions. New York City-based investment firm Lightstone acquired the property from local owner-operator The Davis Cos. Robert Griffin, Jim Tribble, Samantha Hallowell, Tyler McGrail and William Sleeper of Newmark brokered the deal. The property is currently in the midst of a $100 million capital improvement program.
NEW YORK CITY — Rover Diagnostics has signed a 15,763-square-foot life sciences lease in Queens. The space is located on the ground floor of Innolabs, a 266,800-square-foot development in the borough’s Long Island City area. Tom Burrus of JLL represented Rover Diagnostics in the lease negotiations. Bill Harvey and John Cahill, also with JLL, represented the landlord, a partnership between King Street Properties and GFP Real Estate.
RICHARDSON, TEXAS — ANDREW, a hardware manufacturer for the telecommunications industry, has signed a 42,000-square-foot lease in the northeastern Dallas suburb of Richardson. The company is relocating from the nearby building at 2601 Telecom Parkway to the flex building at 2920 Telecom Parkway. In addition to office, the company’s new space supports lab, manufacturing and engineering uses. As part of the relocation, ANDREW plans to invest more than $2 million to support tenant improvements and the addition of new furniture, fixtures and equipment at its new Richardson facility.
WALTHAM, MASS. — Biocytogen, which provides animal and cell model generation for preclinical research, has signed a 35,000-square-foot life sciences lease in Waltham, a western suburb of Boston. Biocytogen now occupies about 70,000 square feet at the 143,533-square-foot building at 300 Third Ave. Tim Allen of Colliers represented the tenant in the lease negotiations. Tim Latham, Christopher Scott and Chris Devaux represented the landlord, Dallas-based Lincoln Property Co., on an internal basis.
BEDFORD, MASS. — A joint venture between Anchor Line Partners and Alloy Properties has refinanced The Core at Crosby, a 615,305-square-foot office and life sciences campus in Bedford, a northwestern suburb of Boston. Berlin Hyp, the commercial real estate finance arm of LBBW, provided the debt for the nine-building campus, which is anchored by software provider AspenTech. Robert Griffin, David Douvadjian Sr., David Douvadjian Jr., Timothy O’Donnell, Edward Maher and Matthew Pullen of Newmark arranged the debt on behalf of the joint venture.
DURHAM, N.C. — Biopharmaceutical company AbbVie (NYSE: ABBV) has announced plans for a new pharmaceutical manufacturing campus located in Durham, according to North Carolina Gov. Josh Stein. AbbVie will invest $1.4 billion in the project over four years, marking the company’s largest capital commitment for a single campus to date and its first investment in the Tarheel State. Last year, AbbVie unveiled plans for a $195 million expansion its manufacturing plan in its hometown of North Chicago. Both projects are part of AbbVie’s $100 billion commitment to grow its U.S. research-and-development and capital investments over the next decade. Upon completion, the Durham campus will total 185 acres and will include drug product manufacturing facilities, next-generation laboratories, a warehouse, administrative offices and employee wellness facilities. AbbVie plans to produce small volume parenteral (i.e. prefilled syringes and vials for injection or infusion) drug products at the facility. Construction of the Durham campus is scheduled to begin this year and be completed by the end of 2028. AbbVie expects the construction process to support 2,000 temporary jobs. Several state and local entities, including The North Carolina Department of Commerce and the Economic Development Partnership of North Carolina, have collaborated with AbbVie on the project. AbbVie …
PHILADELPHIA — Brandywine Realty Trust has received $87.3 million in C-PACE financing for 3151 Market Street, a 494,530-square-foot life sciences facility located within the developer’s Schuylkill Yards mixed-use destination in Philadelphia. The newly completed facility also includes traditional office space in addition to lab facilities and various tenant amenities. Nuveen Green Capital provided the financing, and the deal team says that the amount represents the largest C-PACE loan closing in Pennsylvania’s history. The Philadelphia Energy Authority will administer the financing.
DACULA, GA. — Global biopharmaceutical company UCB has unveiled plans to invest $2 billion to establish its first U.S. pharmaceutical biologics manufacturing campus in Dacula, a city within metro Atlanta’s Gwinnett County. The new facility is expected to create 330 new jobs over the next several years at Rowen, a mixed-use innovation district focused on global health, agriculture and environmental sustainability. The 2,000-acre “knowledge community” is planned along Ga. Highway 316. The new 460,000-square-foot facility will anchor 79 acres that UCB purchased off Rowen Parkway. Brussels, Belgium-based UCB maintains an existing presence in Georgia. The company’s North American headquarters is located in Smyrna and currently supports more than 400 jobs spanning expertise in neurology and immunology. UCB is focused on developing innovative medicines for people living with severe neurological and autoimmune conditions such as epilepsy. UCB’s new manufacturing footprint marks the first major private investment at Rowen and the largest capital investment in Gwinnett County’s history. UCB says it will leverage advanced manufacturing technologies, including artificial intelligence, robotics and automation, while prioritizing efficient use of natural resources. Jean-Christophe Tellier, CEO of UCB, says the project is expected to generate approximately $5 billion in total economic impact, including more than 1,000 …
Newer Posts